XBiotech Inc. — Director's Dealing 2022

Jan 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2021-12-16

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-16	Common Stock	M	250000	$10.00	Acquired	2810964	Direct
2021-12-16	Common Stock	F	213493	$11.71	Disposed	2597471	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-16	Stock Option	$10.00	M	250000	Disposed	2021-12-30	Common Stock (250000)	Direct

Footnotes

F1: Represents a "net exercise" of outstanding stock options. The reporting person received 36,507 shares of common stock on net exercise of option to purchase 250,000 shares of common stock. The Company withheld 213,493 shares of common stock underlying the option for payment of the exercise price using the closing stock price on December 16, 2021 of $11.71, pursuant to the terms of the 2005 Equity Incentive Plan.